中
EN
Team
Portfolio
Insights
Newsroom
About Us
Newsroom
Discover our latest news, recognitions and awards.
All
ESG Spotlight
Qiming News
Portfolio News
All
ESG Spotlight
Qiming News
Portfolio News
09/2024
Portfolio News
Belief BioMed and AskBio, Subsidiary of Bayer, Announced Global Collaboration to Address Unmet Medical Needs with World-Class Gene Therapies
Portfolio News
Insilico Medicine Reports Positive Phase IIa Results for ISM001-055, a Novel First-in-Class Drug Treatment for Idiopathic Pulmonary Fibrosis (IPF) Designed Using Generative AI
Portfolio News
Hydrogen and hydrogen derivatives-fueled gas turbine company Marvel-Tech completed hundreds of millions of RMB Pre-Series B financing round, led by Qiming Venture Partners
06/2024
Qiming News
Qiming's Nisa Leung Made the 2024 Forbes Midas List
05/2024
Qiming News
Qiming Venture Partners Promotes Alex Zhou to Managing Partner
04/2024
Qiming News
Qiming Monthly Newsletter March 2024
03/2024
Portfolio News
Insilico Medicine's Study Published in Nature Biotechnology: First Novel TNIK Inhibitors for Fibrotic Diseases Discovered and Designed Using Generative AI
02/2024
Qiming News
Qiming Venture Partners Becomes a UN PRI Signatory
Qiming News
Qiming EN Newsletter Jan 2024
01/2024
Qiming News
QIMING VENTURE PARTNERS 2024 HEALTHCARE MBA SUMMER INTERNSHIP
Portfolio News
SUPERMAG Raises Over RMB 100 Million in Series A Financing
12/2023
Portfolio News
Qiming Venture Partners' Portfolio Company UBTech Listed on Hong Kong Stock Exchange
Portfolio News
Abbisko Therapeutics Announced the Entry into a Licensing Agreement for Pimicotinib (ABSK021) with Merck
Qiming News
Qiming Monthly Newsletter (November 2023)
11/2023
Portfolio News
Clinical Proteomics Startup Complete Omics Inc. Successfully Completes Series A Financing, Exclusively Invested by Qiming Venture Partners
Qiming News
Qiming Monthly Newsletter (October 2023)
10/2023
Qiming News
Innovation and Technology Venture Fund adds two co-investment partners
Qiming News
Qiming Monthly Newsletter (September 2023)
09/2023
Portfolio News
Qiming Venture Partners' Portfolio Company Tuhu Car Successfully Listed on the Hong Kong Stock Exchange
Qiming News
Qiming Monthly Newsletter (August 2023)
08/2023
Portfolio News
Epigenic Therapeutics Announces $32M in Series A Funding
Qiming News
Qiming Monthly Newsletter (July 2023)
07/2023
Qiming News
Qiming Venture Partners Appoints James Shen as Venture Partner
06/2023
Qiming News
Qiming Venture Partners launches first healthcare catalyst program in Hong Kong, empowering future healthcare scientists
Qiming News
Qiming Monthly Newsletter (May 2023)
05/2023
Portfolio News
LTZ Announces over $10 Million Pre-A+ Financing led by Qiming Venture Partners
Qiming News
Qiming Venture Partners Closes RMB Fund VII at RMB6.5 Billion
Qiming News
Qiming Monthly Newsletter (April 2023)
Qiming News
Qiming's Nisa Leung and Duane Kuang Made 2023 Forbes Midas List
04/2023
Portfolio News
Zai Lab and MediLink Therapeutics Announced Strategic Partnership for a Next Generation Antibody-Drug Conjugate Program in Oncology
Portfolio News
Qiming Venture Partners' portfolio company MedSci successfully listed on HKEX main board
Portfolio News
Belief BioMed Announces a Key Milestone of Dosing Completion for All Subjects in its Registrational Clinical Trial of BBM-H901
Qiming News
Qiming Monthly Newsletter (March 2023)
03/2023
Portfolio News
Qiming Venture Partners Welcomes Apollomics' Successful IPO on Nasdaq
Portfolio News
World's First Quadrivalent COVID-19 Vaccine Developed by SinocellTech is Approved for Emergency Use in China
Portfolio News
Qiming Venture Partners led two consecutive funding rounds in next-generation precision medicine company Allorion Therapeutics
Portfolio News
Allorion Therapeutics, a next-generation precision medicine company focusing on oncology and autoimmune diseases, raises $50 million Series B financing
Qiming News
Qiming Monthly Newsletter (February 2023)
Portfolio News
TandemAI Raises $35 Million in Series A Financing Led by Qiming Venture Partners
02/2023
Portfolio News
Qiming Venture Partners' Portfolio Company LanzaTech Lists on Nasdaq
Portfolio News
Qiming Venture Partners Celebrates Hesai Technology's IPO on Nasdaq
Portfolio News
Qiming Venture Partners Backed Structure Therapeutics Successfully Debuts on Nasdaq
Qiming News
Qiming Monthly Newsletter (January 2023)
01/2023
Portfolio News
China's Leading Adult Interest Learning Service Provider QuantaSing Group Limited Successfully Listed on Nasdaq
Qiming News
Qiming Monthly Newsletter (December 2022)
Qiming News
Qiming Venture Partners 14th CEO Summit successfully concluded
12/2022
Qiming News
Qiming Venture Partners to Hold the 14th CEO Summit This Week
Qiming News
Qiming Venture Partners to Hold the 14th CEO Summit This Week
Qiming News
Merry Christmas!
Qiming News
Qiming Venture Partners to Hold the 14th CEO Summit
Portfolio News
SinocellTech's Recombinant Protein COVID-19 Vaccine SCTV01C Approved for Emergency Use in China
Qiming News
Qiming Monthly Newsletter (November 2022)
Portfolio News
CanSinoBIO's Convidecia Air™ at a Glance
11/2022
Qiming News
Qiming Venture Partners Wins 2022 AVCJ Fundraising of the Year - VC Award
Portfolio News
Insilico Medicine Signs Strategic Research Collaboration with Sanofi worth up to $1.2 Billion
Qiming News
Qiming Monthly Newsletter (October 2022)
10/2022
Portfolio News
CANbridge Announced Encouraging Development in Maralixibat in Rare Liver Disease
Portfolio News
The Case Report of Belief BioMed’s Hemophilia B Gene Therapy Drug Candidate BBM-H901 Published in The New England Journal of Medicine
Portfolio News
CanSinoBIO Celebrates the Rollout of Inhaled Vaccine Convidecia Air™ in Shanghai
Portfolio News
OriCell's GPRC5D CAR-T Received Orphan Drug Designation from FDA
Pages
1
2
3
4
5
6
…
›
»
Team
Portfolio
Insights
Newsroom
About Us
Careers
Contact Us
Legal